Skip to content Skip to footer
Tribe Public CEO Presentation & Q&A: Hosted Friday, August 21 Tribe Public hosts its CEO Presentation and Q&A webinar, “Food Shouldn’t Hurt: EOE, Eupraxia, and a Promising New Treatment Approach,” featuring James Helliwell, MD, Chief Executive Officer of Eupraxia Pharmaceuticals Inc. (NASDAQ:…
A volatile tape has produced an unexpectedly investable combination: major retailers are receiving fresh tariff refunds, mortgage rates have edged lower, and the debate around California’s proposed wealth tax underscores rather than erases Silicon Valley’s enduring economic gravity. For investors, the message…
Tribe Public (www.TribePublic.com) is welcoming James A. Helliwell, M.D., Co-Founder and Chief Executive Officer of Eupraxia Pharmaceuticals (NASDAQ: EPRX), for a timely discussion of Eupraxia’s work in EoE, its proprietary Diffusphere™ drug-delivery platform, and the potential opportunity ahead. Dr. Helliwell brings an…